T J Wilt

Summary

Country: USA

Publications

  1. ncbi request reprint Cernilton for benign prostatic hyperplasia
    T Wilt
    General Internal Medicine, Department of Veterans Affairs Coordinating Center of the, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2000
  2. ncbi request reprint Beta-sitosterols for benign prostatic hyperplasia
    T Wilt
    General Internal Medicine, Department of Veterans Affairs Coordinating Center of the, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2000
  3. ncbi request reprint Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review
    T J Wilt
    Department of Veterans Affairs Coordinating Center of the Cochrane Collaborative Review Group in Prostatic Diseases and Urologic Malignancies, Minneapolis Veterans Affairs Medical Center, Minn 55417, USA
    JAMA 280:1604-9. 1998
  4. ncbi request reprint An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes
    T J Wilt
    Section of General Internal Medicine and Minneapolis VA VISN 13 Center for Chronic Disease Outcomes Research, MN 55417, USA
    Med Care 37:1046-56. 1999
  5. ncbi request reprint Phytotherapy for benign prostatic hyperplasia
    T J Wilt
    Minneapolis VA Center for Chronic Diseases Outcomes Research, MN 55417, USA
    Public Health Nutr 3:459-72. 2000
  6. ncbi request reprint Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects
    R Macdonald
    Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research and the Cochrane Review Group in Prostate Diseases and Urologic Cancers 111 0, Veterans Affairs Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA
    Spinal Cord 45:535-41. 2007
  7. ncbi request reprint Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects
    T J Wilt
    Minneapolis VA Center for Chronic Disease Outcomes Research, the Cochrane Review Group in Prostate Diseases and Urologic Cancers, VA Medical Center, Minneapolis, USA
    BJU Int 89:214-25. 2002
  8. pmc Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis
    S P Elliott
    Department of Urologic Surgery, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    Prostate Cancer Prostatic Dis 14:270-7. 2011
  9. ncbi request reprint Trazodone for erectile dysfunction: a systematic review and meta-analysis
    H A Fink
    Geriatric Research Education and Clinical Center, Section of General Internal Medicine, VA Medical Center, Minneapolis, USA
    BJU Int 92:441-6. 2003
  10. ncbi request reprint Tamsulosin for benign prostatic hyperplasia
    T J Wilt
    General Internal Medicine 111 0, Minneapolis VA VISN 23 Center for Chronic Disease Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2003

Detail Information

Publications16

  1. ncbi request reprint Cernilton for benign prostatic hyperplasia
    T Wilt
    General Internal Medicine, Department of Veterans Affairs Coordinating Center of the, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2000
    ..Cernilton, prepared from the rye-grass pollen Secale cereale, is one of the several phytotherapeutic agents available for the treatment of BPH...
  2. ncbi request reprint Beta-sitosterols for benign prostatic hyperplasia
    T Wilt
    General Internal Medicine, Department of Veterans Affairs Coordinating Center of the, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2000
    ..This systematic review aimed to assess the effects of beta-sitosterols (B-sitosterol) on urinary symptoms and flow measures in men with of benign prostatic hyperplasia (BPH)...
  3. ncbi request reprint Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review
    T J Wilt
    Department of Veterans Affairs Coordinating Center of the Cochrane Collaborative Review Group in Prostatic Diseases and Urologic Malignancies, Minneapolis Veterans Affairs Medical Center, Minn 55417, USA
    JAMA 280:1604-9. 1998
    ....
  4. ncbi request reprint An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes
    T J Wilt
    Section of General Internal Medicine and Minneapolis VA VISN 13 Center for Chronic Disease Outcomes Research, MN 55417, USA
    Med Care 37:1046-56. 1999
    ..To examine temporal trends and geographic variation in utilization of radical prostatectomy (RP) as well as 30-day mortality and complication rates...
  5. ncbi request reprint Phytotherapy for benign prostatic hyperplasia
    T J Wilt
    Minneapolis VA Center for Chronic Diseases Outcomes Research, MN 55417, USA
    Public Health Nutr 3:459-72. 2000
    ..To systematically review the existing evidence regarding the efficacy and safety of phytotherapeutic compounds used to treat men with symptomatic benign prostatic hyperplasia (BPH)...
  6. ncbi request reprint Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects
    R Macdonald
    Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research and the Cochrane Review Group in Prostate Diseases and Urologic Cancers 111 0, Veterans Affairs Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA
    Spinal Cord 45:535-41. 2007
    ..Systematic review...
  7. ncbi request reprint Terazosin for treating symptomatic benign prostatic obstruction: a systematic review of efficacy and adverse effects
    T J Wilt
    Minneapolis VA Center for Chronic Disease Outcomes Research, the Cochrane Review Group in Prostate Diseases and Urologic Cancers, VA Medical Center, Minneapolis, USA
    BJU Int 89:214-25. 2002
    ..To systematically review and evaluate the effectiveness and adverse effects of the alpha-antagonist, terazosin, for treating urinary symptoms associated with benign prostatic obstruction (BPO)...
  8. pmc Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis
    S P Elliott
    Department of Urologic Surgery, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    Prostate Cancer Prostatic Dis 14:270-7. 2011
    ..These findings reflect outcomes for the average patient given the current level of evidence and are meant to help inform current decision-making as we await future clinical studies of comparative effectiveness...
  9. ncbi request reprint Trazodone for erectile dysfunction: a systematic review and meta-analysis
    H A Fink
    Geriatric Research Education and Clinical Center, Section of General Internal Medicine, VA Medical Center, Minneapolis, USA
    BJU Int 92:441-6. 2003
    ..To determine the efficacy and safety of trazodone in the treatment of erectile dysfunction (ED) in a meta-analysis...
  10. ncbi request reprint Tamsulosin for benign prostatic hyperplasia
    T J Wilt
    General Internal Medicine 111 0, Minneapolis VA VISN 23 Center for Chronic Disease Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2003
    ..Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate which can result in bothersome lower urinary tract symptoms. The treatment goal for men with BPH is to relieve these bothersome symptoms...
  11. ncbi request reprint Terazosin for benign prostatic hyperplasia
    T J Wilt
    General Internal Medicine 111 0, Minneapolis VA VISN 13 Center for Chronic Disease Outcomes Research, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2002
    ..To relieve these bothersome symptoms, treatment options include alpha-antagonists, also know as alpha-blockers...
  12. ncbi request reprint Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet
    T J Wilt
    Minneapolis VA Center for Chronic Disease Outcomes Research, University of Minnesota Department of Medicine, Minneapolis, Minn, USA
    Eff Clin Pract 4:112-20. 2001
    ..Although evidence-based guidelines recommend that physicians inform men about prostate cancer screening, the most efficient way to do this is not known...
  13. doi request reprint Five-alpha-reductase Inhibitors for prostate cancer prevention
    T J Wilt
    VAMC, General Internal Medicine 111 0, One Veterans Drive, Minneapolis, Minnesota 55417, USA
    Cochrane Database Syst Rev . 2008
    ..Five-alpha-reductase inhibitors (5ARI) are frequently used to treat bothersome lower urinary tract symptoms associated with benign prostatic hyperplasia and male androgenic alopecia. They have potential as chemopreventive agents...
  14. ncbi request reprint Carotid atherosclerosis in men with low levels of HDL cholesterol
    T J Wilt
    Section of General Internal Medicine, Minneapolis Veterans Affairs VA Medical Center, Minneapolis, MN 55417, USA
    Stroke 28:1919-25. 1997
    ..This article describes the prevalence and correlates of sonographically detected carotid atherosclerosis in men with low levels of HDL-C and CHD but without elevated levels of LDL-C or total cholesterol...
  15. ncbi request reprint Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials
    M D Shelley
    Cochrane Prostatic Diseases and Urologic Cancers Group, Velindre NHS Trust, Cardiff, UK
    BJU Int 93:485-90. 2004
    ....
  16. ncbi request reprint A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?
    M D Shelley
    Cochrane Prostatic Diseases and Urological Cancers Group, Cochrane Unit, Velindre NHS Trust, Cardiff, UK
    Clin Oncol (R Coll Radiol) 16:166-71. 2004
    ..The objective of this review was to compare the overall survival after radical surgery (cystectomy) with radical radiotherapy in patients with muscle-invasive cancer...